N,O-Didesmethyltramadol

Metabolite details

Identifier

CJXNQQLTDXASSR-OCCSQVGLSA-N

InChI Key

CJXNQQLTDXASSR-OCCSQVGLSA-N

IUPAC name

3-[(1R,2R)-1-hydroxy-2-(methylaminomethyl)cyclohexyl]phenol

Preferred name

N,O-Didesmethyltramadol

INN name

—

Synonym

—

ChEBI

CHEBI:173687

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Male_19_days_vs_Male_1_day
• wild_type_vs_patA_deletion